Hospice and Palliative Care

Xeloda for palliation for head and neck cancer – pro

Lay Summary: Xeloda is a reasonable palliative option in metastatic head and neck cancer. Xeloda for palliatve use in head and neck cancer is supported by 2 phase II studies. Xeloda is active in head and neck cancer as it its close relative 5FU and there are a number of studies of Xeloda in combination with platin drugs that confirm its effectiveness. Xeloda is NOT NCCN CHEM-A, 2 recommended as a single agent or in combination for palliation and

Read more